Ridge Biotechnologies
Ridge Bio - Catalyzing the Next Generation of Precision Medicines
Palo Alto, United States · Founded 2024 · $72.0M raised
- Headquarters
- Palo Alto, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- ridgebio.com
- Total Funding
- $72.0M
- Last Round
- $47.0M Series AApr 2026
- Rounds
- 2
About
Ridge Biotechnologies (Ridge Bio) is a Palo Alto-based biotech using proprietary machine learning models and high-throughput cell-free experimentation to design precision enzymes and targeted drug delivery systems. Its NativeLink and ProTrigger platforms enable next-generation antibody-drug conjugates, in vivo CAR-T therapies, and enzyme-based therapeutics. Backed by Sutter Hill Ventures and Overlap Holdings.
Summary
Ridge Biotechnologies is an Artificial Intelligence company based in Palo Alto, United States, founded in 2024. It has raised $72.0M in total across 2 rounds, most recently a $47.0M Series A round in Apr 2026.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...